Clin Neuropharmacol. 1989 Aug;12(4):322-30.

An open label trial of dextromethorphan in Huntington's disease.

Source

Department of Neurology, Wake Forest University, Bowman Gray School of Medicine, Winston-Salem, NC 27103.

Abstract

Because of its interactions at N-methyl-D-aspartate and haloperidol specific sigma receptors, dextromethorphan may have symptomatic or protective effects in Huntington's Disease (HD). Escalating doses of dextromethorphan in 11 HD patients produced side effects of dysarthria, rash, and incoordination. At maximum doses, performance declined on a variety of measures of HD, including functional rating scales and quantitative exam scores, consistent with dose-related side effects. Windows of symptomatic benefit were not found. Serum levels of dextromethorphan and its metabolites, including the active compound dextrorphan, showed atypical relationships to dose and side effects, suggesting complex pharmacokinetics. Although not beneficial symptomatically, further trials of dextromethorphan as protective therapy in HD may be warranted.

PMID:: 2529964; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Molecular Biology Databases

Supplemental Content

Related citations

Olanzapine for Huntington's disease: an open label study. [Clin Neuropharmacol. 2002]
Olanzapine for Huntington's disease: an open label study.
Bonelli RM, Mahnert FA, Niederwieser G. Clin Neuropharmacol. 2002 Sep-Oct; 25(5):263-5.
Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. [Anesthesiology. 2002]
Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials.
Sang CN, Booher S, Gilron I, Parada S, Max MB. Anesthesiology. 2002 May; 96(5):1053-61.
Pharmacokinetics of dextromethorphan and dextrorphan: a single dose comparison of three preparations in human volunteers. [Int J Clin Pharmacol Ther Toxicol. 1987]
Pharmacokinetics of dextromethorphan and dextrorphan: a single dose comparison of three preparations in human volunteers.
Silvasti M, Karttunen P, Tukiainen H, Kokkonen P, Hänninen U, Nykänen S. Int J Clin Pharmacol Ther Toxicol. 1987 Sep; 25(9):493-7.
Review Therapeutic interventions for symptomatic treatment in Huntington's disease. [Cochrane Database Syst Rev. 2009]
Review Therapeutic interventions for symptomatic treatment in Huntington's disease.
Mestre T, Ferreira J, Coelho MM, Rosa M, Sampaio C. Cochrane Database Syst Rev. 2009 Jul 8; (3):CD006456. Epub 2009 Jul 8.
Review Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action. [Neurologist. 2007]
Review Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action.
Werling LL, Lauterbach EC, Calef U. Neurologist. 2007 Sep; 13(5):272-93.

See reviews... See all...

Cited by 1 PubMed Central article

Assessment of the effect of dextromethorphan and ketamine on the acute nociceptive threshold and wind-up of the second pain response in healthy male volunteers. [Br J Clin Pharmacol. 2002]
Assessment of the effect of dextromethorphan and ketamine on the acute nociceptive threshold and wind-up of the second pain response in healthy male volunteers.
Hughes AM, Rhodes J, Fisher G, Sellers M, Growcott JW. Br J Clin Pharmacol. 2002 Jun; 53(6):604-12.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

An open label trial of dextromethorphan in Huntington's disease.
An open label trial of dextromethorphan in Huntington's disease.
Clin Neuropharmacol. 1989 Aug ;12(4):322-30.

PubMed
[Investigation on fats of Virola surinamenis; I. Glyceride and acid composition,...
[Investigation on fats of Virola surinamenis; I. Glyceride and acid composition, and chemical nature of various unsaponificable components].
Rev Farm Bioquim Univ Sao Paulo. 1975 Jan-Jun ;13(1):91-102.

PubMed
Solar retinopathy from sun-gazing under the influence of LSD.
Solar retinopathy from sun-gazing under the influence of LSD.
Br J Ophthalmol. 1973 Apr ;57(4):270-3.

PubMed
An ethnopharmacological examination of Virola elongata bark: a South American ar...
An ethnopharmacological examination of Virola elongata bark: a South American arrow poison.
J Ethnopharmacol. 1984 Oct ;12(1):75-92.

PubMed
Flavonoids and lignans from Virola surinamensis twigs and their in vitro activit...
Flavonoids and lignans from Virola surinamensis twigs and their in vitro activity against Trypanosoma cruzi.
Planta Med. 1998 Oct ;64(7):667-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

An open label trial of dextromethorphan in Huntington's disease.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Related citations

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information